The volume of clinical information that physicians need to retain in order to help determine the best treatment options for their patients is growing to an untenable level. While the amount of data and research is...
The volume of clinical information that physicians need to retain in order to help determine the best treatment options for their patients is growing to an untenable level. While the amount of data and research is...
The acceleration of digital health adoption due to COVID-19 has been welcomed by patients, health care providers, and manufacturers, particularly as governing bodies have been slow to adapt these emerging...
The acceleration of digital health adoption due to COVID-19 has been welcomed by patients, health care providers, and manufacturers, particularly as governing bodies have been slow to adapt these emerging...
Warning of the dangerous impact it will have on seniors with cancer, the Community Oncology Alliance (COA) Board of Directors has submitted a preliminary comment letter to the Centers for Medicare & Medicaid...
Warning of the dangerous impact it will have on seniors with cancer, the Community Oncology Alliance (COA) Board of Directors has submitted a preliminary comment letter to the Centers for Medicare & Medicaid...
While the Association of Community Cancer Centers (ACCC) supports the Center for Medicare and Medicaid Innovation (CMMI) Radiation Oncology (RO) Model’s concept and the transition to value-based care, ACCC has...
While the Association of Community Cancer Centers (ACCC) supports the Center for Medicare and Medicaid Innovation (CMMI) Radiation Oncology (RO) Model’s concept and the transition to value-based care, ACCC has...
The development and introduction of new pharmaceuticals has played a pivotal role in reducing US cancer deaths. While pharmaceuticals have played a significant role in reducing cancer mortality, winning the war on...
The development and introduction of new pharmaceuticals has played a pivotal role in reducing US cancer deaths. While pharmaceuticals have played a significant role in reducing cancer mortality, winning the war on...
Reviewing the latest research on value-based care, clinical pathways, and precision medicine
Cancer Care Pathways in Secondary/Tertiary Care Associated With Shorter LOS
Cancer care pathways in secondary/tertiary...
Reviewing the latest research on value-based care, clinical pathways, and precision medicine
Cancer Care Pathways in Secondary/Tertiary Care Associated With Shorter LOS
Cancer care pathways in secondary/tertiary...
The American Society of Hematology (ASH) is the world’s largest professional society serving both clinicians and scientists working in the hematology field with over 17,000 members from almost 100 countries. The ASH...
The American Society of Hematology (ASH) is the world’s largest professional society serving both clinicians and scientists working in the hematology field with over 17,000 members from almost 100 countries. The ASH...
The Journal of Clinical Pathways (JCP) conducted its third annual survey to better understand pathway use in US oncology practices and cancer centers. Each year this data continues to provide a wealth of...
The Journal of Clinical Pathways (JCP) conducted its third annual survey to better understand pathway use in US oncology practices and cancer centers. Each year this data continues to provide a wealth of...
Abstract: Gastric cancer treatment heterogeneity was assessed over successive updates of clinical pathways. Methods: Patient profiles, treatment patterns, and outcomes were assessed descriptively among adult patients...
Abstract: Gastric cancer treatment heterogeneity was assessed over successive updates of clinical pathways. Methods: Patient profiles, treatment patterns, and outcomes were assessed descriptively among adult patients...
Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.
Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.
This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.
This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.
In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...
In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...
This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...
This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...
In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.
In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.
Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.
Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.
In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.
In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.
NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.